Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Mellitic acid | 1g Pack Size. Group: Building Blocks, Organics. Formula: C12H6O12. CAS No. 517-60-2. Prepack ID 90027024-1g. Molecular Weight 342.17. See USA prepack pricing. |  |
| 1-(Chloroacetyl)-2-(trifluoroacetyl)hydrazine | 1-(Chloroacetyl)-2-(trifluoroacetyl)hydrazine is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 2,2,2-Trifluoroacetic Acid 2-(2-Chloroacetyl)hydrazide; N'-(chloroacetyl)-2,2,2-trifluoroacetohydrazide. Grades: >95%. CAS No. 762240-99-3. Molecular formula: C4H4ClF3N2O2. Mole weight: 204.53. |  |
| 2-Desisopropyl-2-phenyl Repaglinide (Repaglinide Impurity) | An impurity of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Synonyms: 2-Ethoxy-4-[2-oxo-2-[[2-phenyl-1-[2- (1-piperidinyl) phenyl]ethyl]amino]ethyl]benzoic Acid. Grades: > 95%. CAS No. 107362-12-9. Molecular formula: C30H34N2O4. Mole weight: 486.62. | |
| 2-Despiperidyl-2-(5-Carboxypentylamine Repaglinide) (M2 Metabolite) | A metabolite of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Synonyms: 4-[2-[[1-[2-[(4-Carboxybutyl)amino]phenyl]-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; Repaglinide M2 metabolite. Grades: > 95%. CAS No. 874908-12-0. Molecular formula: C27H36N2O6. Mole weight: 484.6. | |
| 2-Keto-D-galactonic acid | 2-Keto-D-galactonic acid is a key compound in the biomedical sphere, assuming a pivotal role in research of conditions like hypertriglyceridemia, diabetes mellitus, and galactosemia. Synonyms: (3S,4S,5R)-3,4,5,6-tetrahydroxy-2-oxohexanoic acid; (3S,4S,5R)-3,4,5,6-tetrahydroxy-2-keto-hexanoic acid; 342385-52-8; L-Xylo-2-Hexulosonic Acid Hydrate; SCHEMBL5807374; AKOS015894428; AC-11922; C03342; (3S,4S,5R)-3,4,5,6-tetrahydroxy-2-oxo-hexanoic acid. CAS No. 16722-49-9. Molecular formula: C6H10O7. Mole weight: 194.14. | |
| 2- methyl enecyclopropaneacetic Acid | 2- methyl enecyclopropaneacetic Acid is an intermediate in the preparation of novel agents for the therapy of non-insulin dependent diabetes mellitus. Group: Biochemicals. Grades: Highly Purified. CAS No. 1073-00-3. Pack Sizes: 500ug, 2.5mg. Molecular Formula: C6H8O2. US Biological Life Sciences. |  Worldwide |
| 3,4:5,6-Di-O-isopropylidene-L-gulonic acid methyl ester | 3,4:5,6-Di-O-isopropylidene-L-gulonic acid methyl ester, a compound of utmost importance within the realm of biomedical research and pharmaceutical progression, serves as a beacon of potential in the treatment and understanding of a myriad of afflictions. With its multifaceted capabilities, it proudly contributes to combating the likes of cardiovascular disorders, diabetes mellitus, and immune-related conditions. Molecular formula: C13H22O7. Mole weight: 290.31. | |
| 3-(((Benzyloxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid | 3-(((Benzyloxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Molecular formula: C18H16F3NO4. Mole weight: 367.32. | |
| 3-O-Acetyl-4-O-methyl-D-glucuronic acid | 3-O-Acetyl-4-O-methyl-D-glucuronic acid is a noteworthy chemical entity used in studying multifarious ailments like carcinoma, diabetes mellitus and inflammatory conditions. Molecular formula: C9H14O8. Mole weight: 250.20. | |
| 4,4'-(2-Acetyl-1,3-glycerol)bisanhydro mellitate | Heterocyclic Organic Compound. Alternative Names: ICI 204,448 hydrochloride, I122_SIGMA, MLS002153186, Ici 204448, Ici-204448, MolPort-003-941-768, CID129407, NCGC00094056-01, SMR001230677, EU-0100704, I-122, 4,4-(2-ACETYL-1,3-GLYCEROL)BISANHYDRO MELLITATE, 121264-04-8, N(1)-(2-(N-Methyl-3,4-dichlorophenylacetamido)-2-(3-carboxyphenyl)ethyl)pyrrolidine, (+/-)-1-[2,3-(Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride, Acetic acid, (3-(1-(((3,4-dichlorophenyl)acetyl)methylamino)-2-(1-pyrrolidinyl)ethyl)phenoxy)-, monohydrochloride, (+-)-, R, S-[3-[1-[[ (3, 4-Dichlorophenyl)acetyl]methylamino]-2- (1-pyrrolidinyl)ethyl] phenoxy]-acetic acid hydrochloride. CAS No. 121264-04-8. Molecular formula: C23H27N2O4Cl3. Mole weight: 501.84. Purity: >98 %. IUPACName: 2-[3-[1-[[2-(3,4-dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]phenoxy]acetic acid hydrochloride. Canonical SMILES: CN (C (CN1CCCC1)C2=CC (=CC=C2)OCC (=O)O)C (=O)CC3=CC (=C (C=C3)Cl)Cl. Cl. Catalog: ACM121264048. |  |
| (5-Hydroxy rosiglitazone)-b-D-glucuronide | (5-Hydroxy rosiglitazone)-b-D-glucuronide is a biochemical compound used as a metabolite marker in diabetes research. Specifically, it is associated with the study of type 2 diabetes mellitus as a breakdown product of rosiglitazone, an antidiabetic medication. Synonyms: 6-[6-({2-[4-Dioxo-thiazolindin-5-yl-methyl)-phenoxy]ethyl}-methyl-amino)-pyridin-3-yloxy]-3,4,5-trihydroxy-tetrahydro-pyran-2-carboxylic acid. CAS No. 288853-59-8. Molecular formula: C24H27N3O10S. Mole weight: 549.55. | |
| 8-Glycine-36-L-argininamide-7-36-Glucagon-like peptide 1 (Octodon degus) TFA | 8-Glycine-36-L-argininamide-7-36-Glucagon-like peptide 1 (Octodon degus) TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2.TFA; L-Histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-L-argininamide trifluoroacetic acid; 7-36-Glucagon-like peptide 1 (Octodon degus), 8-glycine-36-L-argininamide-, trifluoroacetate; Albiglutide TFA; [Gly8,Arg36]-GLP 1 (7-36) amide (Octodon degus) TFA. Grades: ≥95%. Molecular formula: C150H225F3N40O47. Mole weight: 3397.63. | |
| Adomeglivant | Adomeglivant has been found to be a glucagon receptor antagonist that could probably be effective for both type-I and type-II diabetes mellitus. Synonyms: Adomeglivant; LY-2409021; Adomeglivant [USAN]; UNII-74Z5ZL2KVG; LY2409021; LY 2409021; 3- [ [4- [ (1S) -1- [4- (4-tert-butylphenyl) -3, 5-dimethylphenoxy] -4, 4, 4-trifluorobutyl] benzoyl] amino] propanoic acid. Grades: 98%. CAS No. 1488363-78-5. Molecular formula: C32H36F3NO4. Mole weight: 555.64. | |
| AS 1842856 | AS 1842856 is a potent and selective inhibitor of Forkhead box protein O1 transcription factor (FoxO1; IC50 = 33 nM). AS 1842856 reduces glucose production in dose manner via the inhibition of glucose-6 phosphatase and phosphoenolpyruvate carboxykinase mRNA levels in a rat hepatic cell line. AS 1842856 is promisingly to be a therapy of type 2 diabetes mellitus and obesity. Uses: Potential treatment of type 2 diabetes mellitus and obesity. Synonyms: AS1842856; AS-1842856; AS 1842856. 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. Grades: 99%. CAS No. 836620-48-5. Molecular formula: C18H22FN3O3. Mole weight: 347.38. | |
| Bardoxolone methyl | Bardoxolone methyl (also known as "RTA 402" and "CDDO-methyl ester") is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. It is the most potent known inducer of the Nrf2 pathway to enter clinical development and works to suppress both oxidative stress and inflammation. Uses: A nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells; antioxidant inflammation modulator (aim); for the treatment of advanced chronic kidney disease (ckd) in type 2 diabetes mellitus patients. Synonyms: CDDO Methyl ester; CDDOMe; RTA 402; RTA-402; RTA402; TP-155; TP155; TP 155; 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester; bardoxolone methyl; CDDO-Me; methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate; (4aS,6aR,6bS,8aR,12aS,14bS)-Methyl 11-cyano-2, 2, 6a, 6b, 9, 9, 12a-heptamethyl-10, 14-dioxo-1, 2, 3, 4, 4a, 5, 6, 6a, 6b, 7, 8, 8a, 9, 10, 12a, 14, 14a, 14b-octadecahydropicene-4a-carboxylate. Grades: ≥ 98.0%. CAS No. 218600-53-4. Molecular formula: C32H43NO4. Mole weight: 505.70. | |
| Benzyl b-D-glucopyranosiduronic acid | Benzyl b-D-glucopyranosiduronic acid is an innovative compound, unveiling immense prospects in research of glucose metabolism disorder, particularly diabetes mellitus. Synonyms: Benzyl Alcohol Glucuronide. CAS No. 5285-2-9. Molecular formula: C13H16O7. Mole weight: 284.26. | |
| Boc-2-fluoro-D-β-homophenylalanine | Boc-2-fluoro-D-β-homophenylalanine is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-3-((tert-butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic acid; Boc-D-β-HomoPhe(2-F)-OH; Boc-(R)-3-amino-4-(2-fluorophenyl)butyric acid. Grades: >98%. CAS No. 218608-98-1. Molecular formula: C15H20FNO4. Mole weight: 297.32. | |
| Boc-3,4-difluoro-D-beta-homophenylalanine | Boc-3,4-difluoro-D-beta-homophenylalanine is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Boc-(R)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid; (R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid. Grades: >90%. CAS No. 269396-59-0. Molecular formula: C15H19F2NO4. Mole weight: 315.31. | |
| CL-316243 sodium | CL-316243 is a highly selective β3-adrenoceptor agonist with EC50 value of 3 nM; > 10000-fold selective over β1 and β2 receptors. CL-316243 can restore the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice and enhance insulin-stimulated glucose disposal in nonobese rats. Preclical trials for the treatment of Obesity, Overactive bladder and Type 2 diabetes mellitus were discontinued. Uses: Obesity; overactive bladder; type 2 diabetes mellitus. Synonyms: CL-316243 sodium; CL 316243 sodium; CL316243 sodium; disodium;5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate;BTA 243; HP 186; BTA243; HP186; BTA-243; HP-186. Grades: 98%. CAS No. 138908-40-4. Molecular formula: C20H18ClNNa2O7. Mole weight: 465.79. | |
| Colesevelam hydrochloride | Colesevelam is a bile acid sequestrant that helps reduce elevated low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia, and also improve blood glucose balance in adults with type 2 diabetes mellitus. Synonyms: CholestaGel; GT 31-104; GT 31-104HB; Welchol. CAS No. 182815-44-7. Molecular formula: (C13H27N)n. (C12H27ClN2)n. (C3H7N)n. (C3H5ClO)n. xHCl. | |
| Dapagliflozin Impurity 55 | Dapagliflozin Impurity 55 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 2-chloro-5-bromobenzoic acid chloride. Grades: >95%. CAS No. 21900-52-7. Molecular formula: C7H3BrCl2O. Mole weight: 253.91. | |
| Dutogliptin | Dutogliptin is a selective and orally active DPP4 inhibitor. It can improve glycaemic control in patients with type 2 diabetes. But phase III clinical trials for the treatment of type 2 diabetes were discontinued. Uses: Type 2 diabetes mellitus. Synonyms: PHX 1149; PHX1149; PHX-1149; (2R)-1-(((3R)-Pyrrolidin-3-ylamino)acetyl)pyrrolidin-2-yl)boronic acid;890402-81-0 (tartrate salt). Grades: 98%. CAS No. 852329-66-9. Molecular formula: C10H20BN3O3. Mole weight: 241.10. | |
| Exenatide acetate | Exenatide acetate is a potent peptide agonist of the glucagon-like peptide 1 (GLP-1) receptor with Ki value of 136 pM. It is a 39 amino acid peptide, which increases intracellular cAMP in pancreatic acinar cells and has no effect on VIP receptors. It was first isolated from the venom of H. horridum and consequently synthesized. It stimulates proliferation of HCAECs through PKA-PI3K/Akt-eNOS activation pathways via a GLP-1 receptor-dependent mechanism. It also stimulates glucose-induced insulin secretion in isolated rat islets and proinsulin expression in mouse insulinoma βTC-1 cells. It protects hippocampal neurons against glutamate-induced apoptosis, suggesting utility in neurodegenerative diseases. It also has anxiolytic and anti-depressant effects and induces satiety. It is an incretin mimetic approved for type 2 diabetes mellitus treatment. It also has neurotrophic/protective activity in cellular and animal models of stroke, Alzheimer's and Parkinson's diseases. Synonyms: L-Serinamide, L-histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-lysyl-L-asparaginylglycylglycyl-L-prolyl-L-seryl-L-serylglycyl-L-alanyl-L-prolyl-L-prolyl-L-prolyl-, acetate (1:x); Exendin 4 (Heloderma suspectum), acetate; Exendin-4 acetate; H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.CH3CO2H. Grades: >98%. CAS No. 914454-01-6. Molecular formula: C184H282N50O60S.C2H4O2. Mole weight: 4246.61. | |
| Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid | Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: N-β-(9-Fluorenylmethoxycarbonyl)-2,4,5-trifluoro-D-β-homophenylalanine; (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid. Grades: >95%. CAS No. 1217818-53-5. Molecular formula: C25H20F3NO4. Mole weight: 455.43. | |
| Fructosyl-Amino Acid Oxidase from Corynebacterium sp., Recombinant | Fructosamines are formed when glucose is condensed amino group of amino acids or proteins. Fructosamine oxidases (FAOX) catalyze the oxidative deglycation of low molecular weight fructosamines. Fructosyl amino acid oxidase catalyzes the oxidation of the C-N bond linking the C1 of the fructosyl moiety and the nitrogen of the amino group of fructosyl amino acids. Enzyme commission (e.c.) 1.5.3.x, fructosyl amino acid oxidase [fructosyl-a-l-amino acid:oxygen oxidoreductase] is a flavoprotein that catalyzes the oxidation of fructosyl amino acids to form glucosone, amino acid and hydrogen peroxide. Applications: Fructosyl-amino acid oxidase can be used to detect the levels of glycated proteins, which are markers for diabetes mellitus. Group: Enzymes. Synonyms: Fructosyl-Amino Acid Oxidase. Fructosyl-amino acid oxidase. Mole weight: mol wt ~88 kDa by electrophoresis. Activity: > 0.45 units/mg protein. Storage: -20°C. Form: lyophilized powder. Source: E. coli. Species: Corynebacterium sp. Fructosyl-Amino Acid Oxidase. Cat No: NATE-0258. |  |
| GRA Ex-25 | GRA Ex-25 is an orally active human glucagon receptor antagonist in a transgenic murine pharmacodynamic model, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively. GCGR has evolved as an attractive therapeutic target for the treatment of type II diabetes mellitus. Synonyms: 3- (4- ( (1- (4- (tert-butyl) cyclohexyl) -3- (4- (trifluoromethoxy) phenyl) ureido) methyl) benzamido) propanoic acid; GRA Ex-25; GRA Ex 25; GRA Ex25; GRAEx-25; GRAEx 25; GRAEx25. CAS No. 307983-31-9. Molecular formula: C29H36F3N3O5. Mole weight: 563.61. | |
| H-Pro-NH2 | An impurity of Vildagliptin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Synonyms: L-Prolinamide; (2S)-2-Pyrrolidinecarboxamide; (-)-Prolinamide; (2S)-2-Carbamoylpyrrolidine; (2S)-Pyrrolidine-2-carboxylic acid amide; (S)-2-(Aminocarbonyl)pyrrolidine; (S)-Prolinamide; (S)-Proline Amide; 2-Pyrrolidinecarboxamide, (2S)-; 2-Pyrrolidinecarboxamide, (S)-; Prolinamide, L-; (S)-Pyrrolidine-2-carboxamide; (S)-Pyrrolidine-2-carboxylic acid amide; L-Proline amide. Grades: ≥95%. CAS No. 7531-52-4. Molecular formula: C5H10N2O. Mole weight: 114.10. | |
| Indeglitazar | Indeglitazar is a peroxisome proliferator-activated receptor (PPAR) pan-agonist. Phase II clinical trials for Type 2 diabetes mellitus was discontinued. Uses: Type 2 diabetes mellitus. Synonyms: PLX-204; PLX204; PLX 204; PPM-204; PPM204; PPM 204; Indeglitazar; 3-(5-Methoxy-1-((4-methoxyphenyl)sulfonyl)-1H-indol-3-yl)propanoic acid. Grades: 98%. CAS No. 835619-41-5. Molecular formula: C19H19NO6S. Mole weight: 389.43. | |
| LG 100268 | LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM). Group: Biochemicals. Alternative Names: 6-[1- (5, 6, 7, 8-tetrahydro-3, 5, 5, 8, 8-pentamethyl-2-naphthalenyl) cyclopropyl]-3-Pyridinecarboxylic Acid; AGN 192620; ALRT 268; CD 3127; LG 268; LGD 100268; LGD 1268. Grades: Highly Purified. CAS No. 153559-76-3. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C??H??NO?, Molecular Weight: US Biological Life Sciences. | Worldwide |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Synonyms: Linagliptin Related Compound B, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester. Grades: 95%. CAS No. 668273-75-4. Molecular formula: C30H36N8O4. Mole weight: 572.67. | |
| Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate | Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 2,4,5-Trifluoro-β-oxo-benzenebutanoic Acid Methyl Ester; 2,4,5-Trifluoro-beta-oxo-benzenebutanoic acid methyl ester. Grades: >95%. CAS No. 769195-26-8. Molecular formula: C11H9F3O3. Mole weight: 246.18. | |
| MK0533 | MK0533 is a novel selective peroxisome proliferator-activated receptor gamma modulator. It is used for the treatment of type 2 diabetes mellitus. It reduces potential to increase plasma and extracellular fluid volume. It showed diminished maximal activity in cell-based transcription activation assays and attenuated gene signatures in adipose tissue. Uses: Mk0533 is used for the treatment of type 2 diabetes mellitus. Synonyms: MK-0533; MK 0533; (R)-2-(3-(3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)phenoxy)butanoic acid. Grades: 98%. CAS No. 668455-28-5. Molecular formula: C28H24F3NO6. Mole weight: 527.50. | |
| N-acetic acid-1-amino-3-adamantanol | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Synonyms: Vildagliptin Impurity 4; (3-hydroxyadamantan-1-ylamino)acetic acid; 2-((3-Hydroxyadamantan-1-yl)amino)acetic acid. CAS No. 1032564-18-3. Molecular formula: C12H19NO3. Mole weight: 225.29. | |
| Nα-Boc-L-ornithine | Nα-Boc-L-Ornithine, is a boc-protected analogue of L-Orthinine, a non-essential amino acid and intermediate in arginine biosynthesis. It can be used in the enzymatic preparation of N-BOC-5-hydroxy-L-proline, and N-Cbz-5-hydroxy-L-proline, which are alternative key intermediates for the synthesis of Saxagliptin, used for the treatment of type II diabetes mellitus. Synonyms: Boc-L-Orn-OH; (2S)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid; Boc-Orn-OH; L-5-Amino-2-tert-butoxycarbonylamino-pentanoicacid; Boc-L-ornithine; Nalpha-Boc-L-ornithine; N2-Boc-L-ornithine. Grades: ≥ 99% (HPLC). CAS No. 21887-64-9. Molecular formula: C10H20N2O4. Mole weight: 232.30. | |
| (+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate | (+)-Dibenzoyl-D-Tartaric Acid Monohydrate can be used to treat type 2 diabetes mellitus. Synonyms: (2S,3S)-2,3-dibenzoyloxybutanedioic acid;hydrate; (2S,3S)-2,3-dibenzoyloxybutanedioic acid;hydrate. Grades: > 95 %. CAS No. 80822-15-7. Molecular formula: C18H16O9. Mole weight: 376.31. | |
| Perindopril | Perindopril is a long-acting ACE inhibitor. It is used to treat patients with hypertension, diabetes mellitus type 2, coronary heart disease, chronic heart failure or stable coronary artery disease in form of perindopril arginine on the basis of a large evidence. lt has anticancer activity through the inhibition of tumor growth and angiogenesis in hepatocellular carcinoma cells. It suppresses angiotensin II production in vitro. In the in vitro cell proliferation assays, it does not show significant effect on the cell proliferation. In vivo assays demonstrate it can suppress the growth of SCC-VII cells. It is reported that 8 mg perindopril given orally can lower blood pressure without a change in heart rate. It was developed by Xoma. Uses: Perindopril is used to treat patients with hypertension, diabetes mellitus type 2, coronary heart disease, chronic heart failure or stable coronary artery disease in form of perindopril arginine. lt has anticancer activity through the inhibition of tumor growth and angiogenesis in hepatocellular carcinoma cells. Synonyms: MCNA-2833;S-9490; MCNA 2833;S 9490; MCNA2833;S9490; (2S-(1(r*(r*)), 2-alpha, 3a-beta, 7a-beta))-oxopropyl); Octahydro-1-(2-((1-ethoxycarbonyl)butyl)amino)-1-11h-indole-2-carboxylicaci; Coversyl; Perindoprilum; Prestarium; 1-[2-(1-Ethoxycarbonylbutylamino)propanoyl]-2, 3, 3a, 4, 5, 6, 7, 7a-octahydroindole-2-carboxylic acid 2-methyl-2-propanamine (1:1);(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid. Grades: 95%. CAS No. 82834-16-0. Molecular formula: C19H32N2O5. Mole weight: 368.47. | |
| Perindopril Related Compound 6 | An impurity of Perindopril which is used to treat patients with hypertension, diabetes mellitus type 2, coronary heart disease, chronic heart failure or stable coronary artery disease in form of perindopril arginine on the basis of a large evidence. Synonyms: D-Oic-OH; H-D-Oic-OH; D-Octahydroindole-2-carboxylic acid. Grades: > 95%. CAS No. 108507-42-2. Molecular formula: C9H15NO2. Mole weight: 169.22. | |
| PF-04991532 | This active molecular is a hepatoselective glucokinase activator that reduces MDG (mean daily glucose), FPG (fasting plasma glucose) and glucose excursion in humans. PF-04991532 may offer glycemic control without inducing hepatic steatosis. PF-04991532 was developed by Pfizer but was discontinued in Phase-II for Type-2 diabetes mellitus in USA in 2012. Uses: Type 2 diabetes mellitus. Synonyms: PF-04991532; PF 04991532; PF04991532; PF-4991532; PF4991532; PF 4991532; UNII-AJ212MS2O2; CHEMBL2165620; AJ212MS2O2; SCHEMBL1711504; BDBM50394681; 6-[[(2S)-3-cyclopentyl-2-[4-(trifluoromethyl)imidazol-1-yl]propanoyl]amino]pyridine-3-carboxylic acid. Grades: 98%. CAS No. 1215197-37-7. Molecular formula: C18H19F3N4O3. Mole weight: 396.37. | |
| PF 05175157 | PF-05175157 is a selective inhibitor of both acetyl-CoA carboxylase isoform ACC1 and isoform ACC2 dominant. IC50 values are 27 nM and 33 nM, respectively. It was originated by Pfizer. ACC inihibitors can inhibit de novo lipogenesis and increase β-oxidation of long-chain fatty acids. In Feb 2015, Phase-II for Type-2 diabetes mellitus in USA was discontinued. Uses: Type 2 diabetes mellitus. Synonyms: PF-05175157; PF05175157; 1,4-Dihydro-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)-spiro[5H-indazole-5,4'-piperidin]-7(6H)-one. Grades: 98%. CAS No. 1301214-47-0. Molecular formula: C23H27N5O2. Mole weight: 405.50. | |
| Picamilon | Picamilon is an orally active derivative of γ-aminobutyric acid that has nootropic effect. Picamilon improves the epilepsy model in rats and promotes correction of functional disorders of the pancreas during Alloxan (HY-W017227)-induced diabetes mellitus in rats [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Nicotinoyl-GABA; Nicotinoyl-γ-aminobutyric acid. CAS No. 34562-97-5. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg; 1 g. Product ID: HY-107482. |  |
| rac-2-Despiperidyl-2-amino Repaglinide | A metabolite of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Synonyms: 4-[2-[[1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid; Repaglinide M1 Metabolite. Grades: > 95%. CAS No. 874908-11-9. Molecular formula: C22H28N2O4. Mole weight: 384.48. | |
| Repaglinide Acyl-β-D-glucuronide | A metabolite of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Synonyms: 1-[2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoate] β-D-Glucopyranuronic Acid. Grades: > 95%. CAS No. 1309112-13-7. Molecular formula: C33H44N2O10. Mole weight: 628.71. | |
| Repaglinide Impurity A | An impurity of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Synonyms: 4-Carboxy-3-ethoxybenzeneacetic Acid; Repaglinide EP Impurity A. Grades: > 95%. CAS No. 220438-80-2. Molecular formula: C11H12O5. Mole weight: 224.22. | |
| Repaglinide Impurity E | An impurity of Repaglinide, an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Uses: Hypoglycemic agents. Synonyms: 2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid; (-)-Repaglinide; AG-EE 624ZW; Repaglinide EP Impurity E; R-Repaglinide; (R)-(-)-Repaglinide. Grades: > 95%. CAS No. 147852-26-4. Molecular formula: C27H36N2O4. Mole weight: 452.6. | |
| Repaglinide impurity (R-Repaglinide Ethyl Ester) | An impurity of Repaglinide. Repaglinide is an antidiabetic drug. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. Uses: Hypoglycemic agents. Synonyms: 2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid Ethyl Ester. Grades: > 95%. CAS No. 147770-08-9. Molecular formula: C29H40N2O4. Mole weight: 480.65. | |
| (R)-Sitagliptin Defluoro Impurity 3 | Sitagliptin Defluoro Impurity 3 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid; (3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid. Grades: >90%. CAS No. 851307-12-5. Molecular formula: C15H19F2NO4. Mole weight: 315.31. | |
| (R)-Sitagliptin Defluoro Impurity 4 | (R)-Sitagliptin Defluoro Impurity 4 is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin impurity R; (R)-beta-(Boc-amino)-2,5-difluorobenzenebutanoic acid; (R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid. CAS No. 486459-98-7. Molecular formula: C15H19F2NO4. Mole weight: 315.31. | |
| S-(2-Carboxyethyl)-L-cysteine | An advanced glycation end product, found in elevated concentrations within Diabetes Mellitus patients. Group: Biochemicals. Alternative Names: L-3-[ (2-Carboxyethyl) thio]alanine; 2-Amino-4-thiaheptanedioic Acid; S-(2-Carboxyethyl)cysteine; CEC: Grades: Highly Purified. CAS No. 100429-59-2. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Saroglitazar | Saroglitazar is a drug for the treatment of type 2 diabetes mellitus and dyslipidemia. It is approved for use in India by the Drug Controller General of India. Saroglitazar has demonstrated reduction of triglycerides (TG), LDL cholesterol, VLDL cholesterol, non-HDL cholesterol and an increase in HDL cholesterol a characteristic hallmark of atherogenic diabetic dyslipidemia (ADD). Saroglitazar is novel first in class drug which acts as a dual PPAR agonist at the subtypes α (alpha) and γ (gamma) of the peroxisome proliferator-activated receptor (PPAR). Agonist action at PPARα lowers high blood triglycerides, and agonist action on PPARγ improves insulin resistance and consequently lowers blood sugar. Group: Biochemicals. Alternative Names: (α S) -α -Ethoxy-4- [2- [2-methyl-5- [4- (methylthio) phenyl] -1H-pyrrol-1-yl] ethoxy] benzenepropanoic Acid; ZYH1; ZYH-1; ZYH 1; Lipaglyn. IUPAC/Chemical Name: (S) -2-ethoxy-3- (4- (2- (2-methyl-5- (4- (methylthio) phenyl) -1H-pyrrol-1-yl) ethoxy) phenyl) propanoic acid. Grades: Highly Purified. CAS No. 495399-09-2. Pack Sizes: 25mg. Molecular Formula: C??H??NO?S, Molecular Weight: 439.57. US Biological Life Sciences. | Worldwide |
| Saroglitazar | Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity as a drug for the treatment of diabetic dyslipidemia and hypertriglyceridemia with Type 2 diabetes mellitus not controlled by statin therapy. Synonyms: Lipaglyn; ZY-H1; (αS)-α-Ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]benzenepropanoic Acid. Grades: ≥98%. CAS No. 495399-09-2. Molecular formula: C25H29NO4S. Mole weight: 439.57. | |
| Sarpogrelate | Sarpogrelate is a drug under the development of Mitsubishi Chemical as 5HT2A and 5-HT2B receptor. antagonists. It is used as an antiplatelet agent and has been applicated for the treatment of many diseases including coronary artery disease, diabetes mellitus, Buerger's disease, angina pectoris, Raynaud's disease, and atherosclerosis. Uses: Used as an antiplatelet agent. Synonyms: (-)-4-[1-dimethylamino-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid;135159-51-2 (HCl). Grades: 95%. CAS No. 125926-17-2. Molecular formula: C24H31NO6. Mole weight: 429.51. | |
| Sitagliptin Carbamoyl β-D-Glucuronide Methyl Ester | Sitagliptin Carbamoyl β-D-Glucuronide Methyl Ester is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 1-[N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamate] β-D-Glucopyranuronic Acid Methyl Ester. Molecular formula: C24H25F6N5O9. Mole weight: 641.47. | |
| Sitagliptin Carbamoyl β-D-Glucuronide Sodium Salt | Sitagliptin Carbamoyl β-D-Glucuronide Sodium Salt is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 1-[N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamate] β-D-Glucopyranuronic Acid Sodium Salt. Molecular formula: C23H22F6N5NaO9. Mole weight: 649.43. | |
| Sitagliptin Carbamoyl Glucuronide | Sitagliptin Carbamoyl Glucuronide is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-Sitagliptin Carbamoyl Glucuronide; 1-[N-[ (1R) -3-[5, 6-dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamate] β-D-glucopyranuronic acid; Sitagliptin Carbamoyl β-D-Glucuronide. Grades: >90%. CAS No. 940002-59-5. Molecular formula: C23H23F6N5O9. Mole weight: 627.45. | |
| Sitagliptin Carbamoyl Glucuronide Sodium Salt | Sitagliptin Carbamoyl Glucuronide Sodium Salt is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin Carbamoyl β-D-Glucuronide Sodium Salt; 1-[N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamate] β-D-Glucopyranuronic Acid Sodium Salt. Molecular formula: C23H22F6N5NaO9. Mole weight: 649.43. | |
| Sitagliptin Carbamoyl Tri-O-acetyl-β-D-glucuronide Methyl Ester | Sitagliptin Carbamoyl Tri-O-acetyl-β-D-glucuronide Methyl Ester is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 1-[N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamate] Tri-O-acetyl-β-D-glucopyranuronic Acid Methyl Ester. Molecular formula: C30H31F6N5O12. Mole weight: 767.58. | |
| Sitagliptin Defluoro Impurity 3 | Sitagliptin Defluoro Impurity 3 is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 3-((tert-Butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid. CAS No. 1824443-71-1. Molecular formula: C15H19F2NO4. Mole weight: 315.31. | |
| Sitagliptin Defluoro Impurity 4 | Sitagliptin Defluoro Impurity 4 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid; 3-tert-Butoxycarbonylamino-4-(2,5-difluoro-phenyl)-butyric acid. Grades: > 95%. CAS No. 1271773-97-7. Molecular formula: C15H19F2NO4. Mole weight: 315.31. | |
| Sitagliptin FP Impurity E | Sitagliptin FP Impurity E is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin Impurity 17; Sitagliptin Acid Impurity; (βR)-β-Amino-2,4,5-trifluorobenzenebutanoic Acid; (R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid. Grades: >90%. CAS No. 936630-57-8. Molecular formula: C10H10F3NO2. Mole weight: 233.19. | |
| Sitagliptin FP Impurity E Hydrochloride | Sitagliptin EP Impurity E is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin Impurity 17 HCl; Sitagliptin Acid Impurity HCl; (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride; (βR)-β-Amino-2,4,5-trifluorobenzenebutanoic Acid Hydrochloride. Grades: >95%. CAS No. 1204818-19-8. Molecular formula: C10H11ClF3NO2. Mole weight: 269.65. | |
| Sitagliptin Fumarate Adduct (Mixture of Diastereomers) | Sitagliptin Fumarate Adduct is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin Tablets EP Impurity FP-A; Sitagliptin FP Impurity A; N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-L-Aspartic acid; Sitagliptin Maleate adduct. Grades: 95%. CAS No. 2088771-60-0. Molecular formula: C20H19F6N5O5. Mole weight: 523.39. | |
| Sitagliptin Impurity 11 | N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Trifluoroacetic Acid (2Z)-Piperazinylidenehydrazide; N'-[(2Z)-Piperazin-2-ylidene]trifluoroacetohydrazide; N-[(2Z)-Piperazin-2-ylidene]-2,2,2-trifluoroacetohydrazide. Grades: >95%. CAS No. 763105-70-0. Molecular formula: C6H9F3N4O. Mole weight: 210.16. | |
| Sitagliptin Impurity 14 | Sitagliptin Impurity 14 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: 3-amino-4-(2,4,5-trifluorophenyl)butanoic acid ethyl ester. CAS No. 1151240-92-4. Molecular formula: C12H14F3NO2. Mole weight: 261.24. | |
| Sitagliptin Impurity 18 | Sitagliptin Impurity 18 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Sitagliptin N-Boc Impurity; (R)-tert-Butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate; N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]carbamic Acid 1,1-Dimethylethyl Ester. Grades: >95%. CAS No. 486460-23-5. Molecular formula: C21H23F6N5O3. Mole weight: 507.43. | |
| Sitagliptin Impurity 19 | Sitagliptin Impurity 19 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-Sitagliptin N-Boc-Acid Impurity; (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid; Boc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid. Grades: >95%. CAS No. 486460-00-8. Molecular formula: C15H18F3NO4. Mole weight: 333.3. | |
| Sitagliptin Impurity 21 | Sitagliptin Impurity 21 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: Boc-D-β-homophenylalanine; Boc-D-β-Homophe-OH; (R)-3-(Boc-amino)-4-phenylbutyric acid; N-β-(t-Butoxycarbonyl)-D-β-homophenylalanine. Grades: >97%. CAS No. 101555-61-7. Molecular formula: C15H21NO4. Mole weight: 279.33. | |
| Sitagliptin N-Phoshate Impurity | Sitagliptin N-Phoshate Impurity is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)phosphoramidic acid. Grades: > 95%. CAS No. 1351498-25-3. Molecular formula: C16H16F6N5O4P. Mole weight: 487.29. | |
| Sitagliptin N-Sulfate | Sitagliptin N-Sulfate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]sulfamic Acid; (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)sulfamic acid. Grades: > 95%. CAS No. 940002-57-3. Molecular formula: C16H15F6N5O4S. Mole weight: 487.38. | |
| Sitagliptin N-Sulfate Sodium Salt | Sitagliptin N-Sulfate Sodium Salt is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: N-[ (1R) -3-[5, 6-Dihydro-3- (trifluoromethyl) -1, 2, 4-triazolo[4, 3-a]pyrazin-7 (8H) -yl]-3-oxo-1-[ (2, 4, 5-trifluorophenyl) methyl]propyl]sulfamic Acid Sodium Salt; (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)sulfamate, monosodium salt. Grades: >95%. Molecular formula: C16H14F6N5O4NaS. Mole weight: 509.36. | |
| Sitagliptin Related Compound 1 | Sitagliptin Related Compound 1 is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Synonyms: (R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic acid; Boc-(R)-3-amino-4-(3-fluorophenyl)-butyric acid. Grades: >95%. CAS No. 331763-66-7. Molecular formula: C15H20FNO4. Mole weight: 297.32. | |
Our database is helping our users find suppliers everyday.
